Cannabis
Topic
Check out the latest Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
LATEST CANNABIS NEWS
Big pharma Sandoz steps into Aussie CBD scene; could this be the start of a rush?
Argent and AusCann partner to accelerate cannabinoid pharma development
Argent secures deal for Malta manufacturing facility, unlocking US$1m in cost savings
Argent soars as cannabinoid-based epilepsy drug gains approval in Germany
StockTake: Bioxyne’s deal to boost supply pipeline
StockTake: $3M for Euro market push
Psilocybin can tackle brain injuries and binge eating, and these ASX companies are in the game
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Health Check: Latest biotech quarterly results are as patchy as the curate’s egg
Bioxyne’s revenue soars 48pc after key manufacturing licences boost growth
Health Check: Long-suffering Mesoblast investors dare to dream
Health Check: Cancer drug developer Chimeric heads to blood bank for better patient cells
AGH raises $2 million for its US cannabis beverage market expansion
